Table 1.
Target or bioactivity | Number of compounds
|
|
---|---|---|
Clinical collection | Approved oncology drugs set | |
DNA damage/repair | 7 | 21 |
Hormones | 6 | 2 |
Psychoactive drugs | 14 | 0 |
Tyrosine kinase inhibitors | 0 | 4 |
Ion channel inhibitors | 3 | 0 |
Antihistamines | 4 | 0 |
Target adenosine receptor | 3 | 0 |
Target adrenergic receptor | 2 | 0 |
Unclassified | 11 | 3 |